Study of NTBC for Tyrosinemia I

Completed · Not applicable

Conditions studied: Tyrosinemia I

In brief

OBJECTIVES: I. Assess the safety and efficacy of NTBC in children with tyrosinemia I. II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in renal tubular damage, reduction in the need for liver transplantation, and reduction in the development of hepatocarcinoma in these patients.

Key facts

Study ID

NCT00004443

Run by

University of Washington

People needed

20

Starts

1998-10-01

Expected to finish

2006-09-01

Last updated by the study team

2015-03-25

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Oregon Health Sciences University — Portland, Oregon, United States
• University of Washington School of Medicine — Seattle, Washington, United States
• Hopital Sainte Justine — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.